976 related articles for article (PubMed ID: 28756234)
1. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
Bloemendaal FM; Levin AD; Wildenberg ME; Koelink PJ; McRae BL; Salfeld J; Lum J; van der Neut Kolfschoten M; Claassens JW; Visser R; Bentlage A; D'Haens GRAM; Verbeek JS; Vidarsson G; van den Brink GR
Gastroenterology; 2017 Nov; 153(5):1351-1362.e4. PubMed ID: 28756234
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner.
Vos AC; Wildenberg ME; Duijvestein M; Verhaar AP; van den Brink GR; Hommes DW
Gastroenterology; 2011 Jan; 140(1):221-30. PubMed ID: 20955706
[TBL] [Abstract][Full Text] [Related]
3. Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro.
Vos AC; Wildenberg ME; Arijs I; Duijvestein M; Verhaar AP; de Hertogh G; Vermeire S; Rutgeerts P; van den Brink GR; Hommes DW
Inflamm Bowel Dis; 2012 Mar; 18(3):401-8. PubMed ID: 21936028
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice.
López-Posadas R; Fastancz P; Martínez-Sánchez LDC; Panteleev-Ivlev J; Thonn V; Kisseleva T; Becker LS; Schulz-Kuhnt A; Zundler S; Wirtz S; Atreya R; Carlé B; Friedrich O; Schürmann S; Waldner MJ; Neufert C; Brakebusch CH; Bergö MO; Neurath MF; Atreya I
Gastroenterology; 2019 Nov; 157(5):1293-1309. PubMed ID: 31302143
[TBL] [Abstract][Full Text] [Related]
5. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.
Ungaro R; Fukata M; Hsu D; Hernandez Y; Breglio K; Chen A; Xu R; Sotolongo J; Espana C; Zaias J; Elson G; Mayer L; Kosco-Vilbois M; Abreu MT
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1167-79. PubMed ID: 19359427
[TBL] [Abstract][Full Text] [Related]
6. The tumor necrosis factor family member TNFSF14 (LIGHT) is required for resolution of intestinal inflammation in mice.
Krause P; Zahner SP; Kim G; Shaikh RB; Steinberg MW; Kronenberg M
Gastroenterology; 2014 Jun; 146(7):1752-62.e4. PubMed ID: 24560868
[TBL] [Abstract][Full Text] [Related]
7. Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling.
Koelink PJ; Bloemendaal FM; Li B; Westera L; Vogels EWM; van Roest M; Gloudemans AK; van 't Wout AB; Korf H; Vermeire S; Te Velde AA; Ponsioen CY; D'Haens GR; Verbeek JS; Geiger TL; Wildenberg ME; van den Brink GR
Gut; 2020 Jun; 69(6):1053-1063. PubMed ID: 31506328
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis.
Terabe F; Fujimoto M; Serada S; Shinzaki S; Iijima H; Tsujii M; Hayashi N; Nomura S; Kawahata H; Jang MH; Miyasaka M; Mihara M; Ohsugi Y; Kishimoto T; Naka T
Inflamm Bowel Dis; 2011 Feb; 17(2):491-502. PubMed ID: 20602470
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease.
Levin AD; Wildenberg ME; van den Brink GR
J Crohns Colitis; 2016 Aug; 10(8):989-97. PubMed ID: 26896086
[TBL] [Abstract][Full Text] [Related]
10. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
11. Fc Receptor-mediated Effector Function Contributes to the Therapeutic Response of Anti-TNF Monoclonal Antibodies in a Mouse Model of Inflammatory Bowel Disease.
McRae BL; Levin AD; Wildenberg ME; Koelink PJ; Bousquet P; Mikaelian I; Sterman AS; Bryant S; D'Haens G; Kamath R; Salfeld J; van den Brink GR
J Crohns Colitis; 2016 Jan; 10(1):69-76. PubMed ID: 26429698
[TBL] [Abstract][Full Text] [Related]
12. Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's disease.
Dige A; Magnusson MK; Öhman L; Hvas CL; Kelsen J; Wick MJ; Agnholt J
Scand J Gastroenterol; 2016; 51(6):692-9. PubMed ID: 26784676
[TBL] [Abstract][Full Text] [Related]
13. Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis.
Punit S; Dubé PE; Liu CY; Girish N; Washington MK; Polk DB
Gastroenterology; 2015 Oct; 149(4):993-1005.e2. PubMed ID: 26072395
[TBL] [Abstract][Full Text] [Related]
14. The role of Gr-1(+) cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice.
McDermott AJ; Higdon KE; Muraglia R; Erb-Downward JR; Falkowski NR; McDonald RA; Young VB; Huffnagle GB
Immunology; 2015 Apr; 144(4):704-16. PubMed ID: 25399934
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
16. Natural killer T cell activation increases iNOS
Paul S; Chhatar S; Mishra A; Lal G
J Immunother Cancer; 2019 Aug; 7(1):208. PubMed ID: 31387637
[TBL] [Abstract][Full Text] [Related]
17. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
[TBL] [Abstract][Full Text] [Related]
18. Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
Popp V; Gerlach K; Mott S; Turowska A; Garn H; Atreya R; Lehr HA; Ho IC; Renz H; Weigmann B; Neurath MF
Gastroenterology; 2017 Jan; 152(1):176-192.e5. PubMed ID: 27639807
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
Atreya R; Zimmer M; Bartsch B; Waldner MJ; Atreya I; Neumann H; Hildner K; Hoffman A; Kiesslich R; Rink AD; Rau TT; Rose-John S; Kessler H; Schmidt J; Neurath MF
Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
[TBL] [Abstract][Full Text] [Related]
20. TNF-anti-TNF Immune Complexes Inhibit IL-12/IL-23 Secretion by Inflammatory Macrophages via an Fc-dependent Mechanism.
Bloemendaal FM; Koelink PJ; van Schie KA; Rispens T; Peters CP; Buskens CJ; van der Bilt JD; Bemelman WA; Korf H; Sabino JG; Ponsioen CY; Te Velde AA; D'Haens GRAM; Vermeire S; van den Brink GR; Wildenberg ME
J Crohns Colitis; 2018 Aug; 12(9):1122-1130. PubMed ID: 29860435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
